Clinical Trials Logo
  1. Home
  2. Genital Diseases, Female
  3. NCT02097446

Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy — GUARDIX-FL  

Genital Diseases, Female Clinical Trial

Official title:
Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy : A Prospective, Randomized, Controlled Study

Clinical Trial Summary

- Indication: Benign tumors of ovary(mature teratoma, mucinous cystadenoma, serous cystadenoma)

- Intervention: Device ( Test group : Guardix-FL, Control group : Interceed)

- Primary Outcome Measure : Anti-adhesion Rate

- Assessment : Operative Day(Visit 2), Post-Operative Day+7days(Vist 3), Post-Operative Day+4weeks(Visit4), Post-Operative Day+5weeks(Visit 5)

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Supportive Care

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02097446
Study type Interventional
Source Genewel Co., Ltd
Contact Jun Ho Kim, Master
Phone 82-10-6455-3455
Email junho1012@idongsung.com
Status Not yet recruiting
Phase Phase 3
Completion date January 2015
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04566952 - Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Phase 2
Completed NCT03562897 - Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer Phase 2
Completed NCT01456962 - Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract N/A
Completed NCT01460979 - Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma Phase 2
Completed NCT00050414 - A Study of Trabectedin in Patients With Advanced Ovarian Cancer Phase 2
Completed NCT01526668 - Follow-up Strategies for Improved Postoperative Recovery After Benign Hysterectomy N/A
Recruiting NCT04556071 - Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer Phase 2
Completed NCT01462890 - Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer Phase 3
Completed NCT01523652 - Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients N/A
Recruiting NCT06134596 - Correlation of Clitoral Hood and Labia Minora Measurements and Female Genital Self Image Scale (FGSIS) Scores in Women
Completed NCT02747641 - Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects N/A
Completed NCT00365716 - Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED) Phase 2
Completed NCT03677336 - Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI Phase 4
Completed NCT02698527 - The Effect of Buffered Lidocaine Versus Nonbuffered Lidocaine on Pain Scores During Infiltration for Vulvar Biopsies N/A
Not yet recruiting NCT04807166 - Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer Phase 2
Completed NCT04858919 - Transrectal and 3D Transabdominal Ultrasound Compared to Vaginoscopy in Diagnosing Virgins With Genital Lesions N/A
Completed NCT01628432 - Effect of Salpingectomy During Conservative Hysterectomy N/A
Active, not recruiting NCT01271400 - LANDA Embryo Freezing Technique. N/A
Completed NCT02642835 - A Long Term Follow up of Anterior Meshes for Recurrent Prolapse
Recruiting NCT04061967 - SMS-based Summons in Cervical Screening N/A